MGMT and glioma: We applied the multivariate Cox regression analysis to investigate the prognostic power of the signature, and the result revealed that the expression ofMLLT11 hazard ratios (HR) = 0.47, p < 0.026) is an independent prognostic biomarker for glioma patients after adjusting for age, gender, IDH, MGMT promoter, Telomerase reverse transcriptase (TERT) promoter, and 1p19q codeletion status (Figure 3I).